Glanbia plc (GLAPF) Stock Analysis
Educational signal · not a buy or sell recommendation · How to read this
P/E 26.00 means the share price is 26.00 times one year of earnings per share; the S&P 500 usually sits near 20-25. Market cap $6.26B is the value of all shares combined. Beta 0.52: the stock has moved about 48% less than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerGlanbia plc (GLAPF) trades at $25.90. Glanbia plc is a global nutrition company operating across sports and lifestyle nutrition, as well as dairy and plant-based ingredients. Market cap: $6.26B, Sector: Consumer defensive.
Price as of Sep 11, 2026 · Last analyzed: Jun 15, 2026Analyst Coverage for GLAPF: GLAPF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates GLAPF against Consumer Defensive peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
No score published: this stock trades under $10,000 on a typical day, so the price beside it is not one you could reliably act on.
GLAPF: 1/2 scored disciplines lean bullish. Dominant signal: Ken Griffin bullish.
How is this calculated? →AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Glanbia plc (GLAPF) Consumer Business Overview
Glanbia plc is a global nutrition leader specializing in sports, lifestyle, and functional ingredients, leveraging a diverse brand portfolio including OPTIMUM NUTRITION and SlimFast. The company distributes products through extensive channels, from specialty retail to mass merchandisers, supported by integrated R&D and manufacturing capabilities.
What Is the Investment Thesis for GLAPF?
The company benefits from strong brand equity in sports and lifestyle nutrition, exemplified by OPTIMUM NUTRITION, alongside a robust B2B ingredients business. Its global distribution network and continuous product innovation align with growing consumer demand for health and wellness products. Financially, Glanbia demonstrates a solid gross margin of 26.0% and a profit margin of 4.6%, indicating efficient operations. The dividend yield of 1.96% offers income potential, while a Beta of 0.52 suggests lower volatility relative to the broader market. Key value drivers include expansion in plant-based offerings, leveraging e-commerce channels, and penetration into emerging markets. Investors may want to evaluate the P/E ratio of 26.00 relative to industry peers and the ongoing competitive landscape in the packaged foods sector.
Based on FMP financials and quantitative analysis
GLAPF Key Highlights
Market Capitalization of $6.26B, reflecting its substantial presence in the global nutrition industry.
- Gross Margin of 26.0%, indicating effective cost management and pricing power across its product categories.
- Profit Margin of 4.6%, demonstrating the company's ability to translate sales into net income amidst operational complexities.
- P/E ratio of 26.00, suggesting investor confidence in future earnings growth or a premium for its stable consumer defensive characteristics.
- Dividend Yield of 1.96%, providing a consistent return to shareholders, characteristic of a mature, stable company.
Who Are GLAPF's Competitors?
GLAPF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| TATYY Tate & Lyle plc | $30.23 | -0.40% | $7.17B | — |
| TSUKF Toyo Suisan Kaisha, Ltd. | $65.32 | 0.00% | $6.33B | 499-signal |
| NSLYF Nestlé (Malaysia) Berhad | $26.49 | 0.00% | $6.21B | — |
| CPB Campbell Soup Company | $20.94 | -4.30% | $6.24B | 535-pillar |
| INGR Ingredion Incorporated | $101.13 | +0.41% | $6.38B | 805-pillar |
| LW Lamb Weston Holdings, Inc. | $47.32 | -1.68% | $6.51B | 675-pillar |
| CAG Conagra Brands, Inc. | $14.71 | -2.65% | $7.04B | 425-pillar |
| PPC Pilgrim's Pride Corporation | $29.93 | -1.03% | $7.12B | 635-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.
What Are GLAPF's Key Strengths?
Robust portfolio of globally recognized sports and lifestyle nutrition brands.
- Dual business model with stable B2B ingredient sales complementing consumer products.
- Extensive global distribution network across diverse retail and online channels.
- Strong R&D capabilities driving product innovation in nutrition and ingredients.
What Are GLAPF's Weaknesses?
Exposure to volatile raw material costs, particularly for dairy and agricultural inputs.
- Highly competitive market landscape in both consumer nutrition and ingredient sectors.
- Reliance on consumer trends and preferences, which can shift rapidly.
- OTC listing may impact liquidity and investor perception compared to major exchanges.
What Could Drive GLAPF Stock Higher?
GLAPF catalyst: **Product Innovation and Portfolio Expansion**: Continuous introduction of new sports and lifestyle nutrition products, particularly in plant-based or functional formats, could drive sales growth and market share.
- **E-commerce Channel Optimization**: Further investment and success in expanding online sales platforms and direct-to-consumer channels could enhance reach and profitability.
- **Strategic Market Penetration**: Successful expansion into high-growth emerging markets, leveraging existing global infrastructure, could unlock new revenue streams.
- **Efficiency Improvements**: Implementation of cost-saving measures or supply chain optimizations could lead to improved profit margins and overall financial performance.
- **Demand for Nutritional Ingredients**: Sustained or increased demand from other food and beverage manufacturers for Glanbia's dairy, plant-based, and vitamin/mineral premixes.
What Are the Key Risks for GLAPF?
**Raw Material Price Volatility**: Fluctuations in the cost of dairy, plant-based proteins, and other agricultural commodities could impact Glanbia's gross margins.
- **Intense Competitive Landscape**: The nutrition and packaged foods sectors are highly competitive, with numerous global and local players vying for market share, potentially pressuring pricing and innovation.
- **Shifts in Consumer Preferences**: Rapid changes in dietary trends or health perceptions could reduce demand for certain product lines, requiring significant R&D investment to adapt.
- **Regulatory and Compliance Challenges**: Operating globally exposes Glanbia to diverse food safety, labeling, and import/export regulations, which can be complex and costly to navigate.
- **OTC Market Liquidity and Transparency**: The 'OTC Other' listing with unknown disclosure status poses risks of lower trading liquidity and limited access to critical financial information for investors.
What Are the Growth Opportunities for GLAPF?
- **Expansion in Global Sports and Lifestyle Nutrition Market**: The global sports and lifestyle nutrition market continues to expand, driven by increasing health consciousness, rising participation in fitness activities, and a growing demand for convenient, functional foods. Glanbia, with its strong portfolio of brands like OPTIMUM NUTRITION and BSN, is well-positioned to capture a larger share of this market. Projections indicate sustained growth in this sector, with market sizes reaching tens of billions globally by the end of the decade. By continually innovating and expanding its product formats, such as ready-to-drink beverages and protein bars, Glanbia can cater to diverse consumer needs and preferences, driving revenue growth over the next 3-5 years.
- **Leveraging the Plant-Based Nutrition Trend**: The shift towards plant-based diets and sustainable food choices represents a significant growth opportunity. Glanbia's existing capabilities in dairy and plant-based nutritional and functional ingredients, along with brands like Amazing Grass, allow it to capitalize on this trend. By investing further in plant-based protein research, product development, and expanding its ingredient offerings to other manufacturers, Glanbia can tap into a rapidly growing consumer segment and diversify its revenue streams, with significant impact expected within the next 2-4 years.
- **Enhanced E-commerce and Direct-to-Consumer (DTC) Channels**: The increasing digitalization of retail offers substantial growth for Glanbia. By strengthening its e-commerce platforms and DTC capabilities, the company can achieve wider market penetration, reduce reliance on traditional retail, and build stronger direct relationships with consumers. This strategy allows for more targeted marketing, faster product launches, and improved customer insights. The online grocery and supplement market continues to grow at double-digit rates annually. Optimizing its digital presence and supply chain for online fulfillment can significantly boost sales and brand loyalty, particularly for its sports nutrition brands, over the next 1-3 years.
- **Penetration into Emerging Markets**: Many emerging economies are experiencing rising disposable incomes and a growing middle class, leading to increased demand for branded food and nutrition products. Glanbia's global operational footprint provides a foundation for strategic expansion into these high-growth markets in Asia, Latin America, and Africa. Tailoring products to local tastes and nutritional needs, while leveraging its established supply chains, can unlock substantial new customer bases. The long-term growth potential in these regions is considerable, offering a multi-decade opportunity for market share gains and revenue diversification.
- **Increased Demand for Functional Ingredients**: Beyond consumer products, the demand for specialized nutritional and functional ingredients from other food and beverage manufacturers is consistently growing. This includes dairy and plant-based proteins, as well as vitamin and mineral premixes. As manufacturers seek to fortify their products and cater to specific health claims, Glanbia's expertise as a B2B supplier becomes increasingly valuable. This segment provides a stable, high-margin revenue stream, less susceptible to direct consumer marketing fluctuations. Continued investment in R&D for novel ingredients and strategic partnerships with food industry players can solidify Glanbia's position as a preferred supplier for the foreseeable future.
What Threats Does GLAPF Face?
- Intense competition from both established players and new entrants in the nutrition market.
- Regulatory changes impacting food labeling, health claims, or ingredient approvals.
- Economic downturns affecting consumer discretionary spending on premium nutrition products.
- Supply chain disruptions or adverse weather events impacting agricultural raw material availability.
What Are GLAPF's Competitive Advantages?
- **Strong Brand Portfolio**: Established and recognized brands like OPTIMUM NUTRITION and SlimFast command consumer loyalty and premium pricing.
- **Global Distribution Network**: Extensive reach across diverse channels, including online, specialty, and mass retail, ensures broad market access.
- **Integrated Supply Chain & R&D**: Control over ingredient sourcing, manufacturing, and continuous innovation in both consumer products and B2B ingredients.
- **Diversified Business Segments**: Revenue streams from both branded consumer goods and B2B ingredient sales provide stability and reduce reliance on a single market segment.
- **Scale and Operational Efficiency**: As a large global player, Glanbia benefits from economies of scale in procurement, production, and distribution.
What Does GLAPF Do?
Established in 1964 and headquartered in Kilkenny, Ireland, Glanbia plc has evolved into a prominent global entity within the nutrition industry. The company operates a dual-pronged business model, encompassing both consumer-facing sports and lifestyle nutrition products and a significant ingredients segment. In its consumer division, Glanbia is actively involved in the creation and distribution of a wide array of products, available in diverse formats such as powdered supplements, convenient ready-to-eat bars and snacks, and ready-to-drink beverages. This extensive product line is supported by a robust portfolio of well-known brands, including OPTIMUM NUTRITION, SlimFast, BSN, ISOPURE, NUTRAMINO, think!, Amazing Grass, and BODY&FIT. These products reach consumers through a comprehensive network of distribution channels, including specialized retail outlets, online platforms, fitness centers, and major commercial avenues such as grocery stores, pharmacies, mass merchandisers, and membership clubs. Beyond consumer products, Glanbia is a significant producer and supplier of essential nutritional and functional ingredients. This includes cheese, various dairy and plant-based ingredients, and vital vitamin and mineral premixes, serving other food and beverage manufacturers globally. The company's operations further extend into areas such as financing, research and development, real estate transactions, receivables management, property leasing, and offering weight management solutions, in addition to other business and management services. This integrated approach, combining strong brand presence with a foundational ingredients business and diverse operational support, positions Glanbia as a comprehensive player in the global nutrition landscape, catering to evolving consumer health and wellness trends.
What Products and Services Does GLAPF Offer?
- Manufacture and sell sports nutrition products like protein powders, bars, and ready-to-drink beverages.
- Produce and distribute lifestyle nutrition products, including weight management solutions and healthy snacks.
- Operate a portfolio of well-known brands such as OPTIMUM NUTRITION, SlimFast, BSN, and Amazing Grass.
- Manufacture and supply cheese, dairy, and plant-based nutritional and functional ingredients to other businesses.
- Produce and supply vital vitamin and mineral premixes for the food and beverage industry.
- Distribute products through diverse channels including specialty retail, online platforms, gyms, grocery stores, and pharmacies.
- Engage in financing, research and development, and property management activities related to its core business.
- Offer business and management services, including receivables management and property leasing.
How Does GLAPF Make Money?
- **Branded Consumer Products**: Generates revenue through the sale of its proprietary sports and lifestyle nutrition brands (e.g., OPTIMUM NUTRITION, SlimFast) directly to consumers via retail, online, and specialized channels.
- **B2B Nutritional Ingredients**: Earns revenue by supplying dairy, plant-based, and functional ingredients, including cheese and vitamin/mineral premixes, to other food and beverage manufacturers globally.
- **Diversified Distribution**: Utilizes a multi-channel approach, including specialty retail, e-commerce, fitness centers, and mass market retailers, to maximize product reach and sales.
- **Innovation and R&D**: Invests in research and development to create new products and ingredients, maintaining a competitive edge and responding to evolving consumer health trends.
What Industry Does GLAPF Operate In?
Glanbia plc operates within the dynamic Packaged Foods industry, specifically carving out a significant niche in the broader nutrition sector. This industry is characterized by evolving consumer preferences towards health, wellness, and convenience, driving demand for functional foods, sports nutrition, and plant-based alternatives. Glanbia's dual focus on branded consumer products and nutritional ingredients positions it uniquely to capitalize on these trends. The competitive landscape is fragmented, featuring large multinational conglomerates and specialized niche players. Glanbia differentiates itself through a strong portfolio of recognized brands like OPTIMUM NUTRITION and SlimFast, coupled with its robust B2B ingredients business, which provides a stable revenue stream and hedges against consumer market volatility. The company's global reach and R&D capabilities enable it to adapt to regional tastes and regulatory environments, maintaining its competitive edge in a market driven by innovation and brand loyalty.
Who Are GLAPF's Key Customers?
- **Individual Consumers**: Health-conscious individuals, athletes, and those seeking weight management or lifestyle nutrition products.
- **Specialty Retailers**: Stores focused on sports nutrition, health foods, and dietary supplements.
- **Major Retail Chains**: Grocery stores, pharmacies, mass merchandisers, and membership clubs carrying packaged food and nutrition products.
- **Food & Beverage Manufacturers**: Companies that incorporate Glanbia's dairy, plant-based, and functional ingredients into their own products.
- **Fitness Centers & Gyms**: Establishments that sell sports nutrition products directly to their members.
Research confidence
Enough evidence to be useful, with gaps worth knowing about.
- ● Scoring coverage unknown
- ● Price is current
- ● Latest filing 73 days ago
- ● No analyst coverage
MoonshotScore History
Recorded daily since 2026-08-23 · 19 snapshots
| 2026-08-23 | 48 |
| 2026-08-26 | 48 |
| 2026-08-29 | 48 |
| 2026-09-01 | 48 |
| 2026-09-04 | 48 |
| 2026-09-07 | 48 |
| 2026-09-10 | 48 |
What changed?
The score has stayed at 48.
Over the same 18 days the stock moved +0.0%.
Company Profile
Glanbia plc operates in the Packaged Foods industry within the Consumer Defensive sector. It is headquartered in Kilkenny, IE. The company is led by CEO Hugh McGuire Finance. GLAPF has traded publicly since 2012.
Key Financial Metrics
Return on equity for Glanbia plc stands at 12.3%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 5.9%, showing how much profit it generates from its asset base. GLAPF trades at a trailing price-to-earnings ratio of 26.00, roughly in line with the Consumer Defensive sector average of ~27.60x. Its free cash flow yield is 5.9%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.53 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 3.7%, the inverse of the P/E and a quick read on earnings relative to price.
GLAPF Valuation & Market Position
With a $6.26B market cap, Glanbia plc sits in the mid-cap segment of the market.
Quarterly Financial Performance: Glanbia plc
Revenue for Glanbia plc came in at $2.04B during Q2 FY2026. The company recorded net income of $150.6M, with diluted EPS of $0.62. Revenue has increased across the last three reported quarters, suggesting sustained momentum for this mid-cap Consumer Defensive company. Across the four most recent quarters, GLAPF averaged $0.43 in diluted EPS.
Financial Health
Glanbia plc's Piotroski F-Score is 6/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 5.20 places it in the safe zone, indicating low near-term bankruptcy risk.
Earnings Track Record
Glanbia plc has beaten Wall Street's EPS estimate in 7 of its last 8 reported quarters — a consistent record of delivering on expectations. Reported results have landed about 5.5% above estimates on average.
GLAPF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Robust portfolio of globally recognized sports and lifestyle nutrition brands.
- Dual business model with stable B2B ingredient sales complementing consumer products.
- Extensive global distribution network across diverse retail and online channels.
- Strong R&D capabilities driving product innovation in nutrition and ingredients.
Bear Case
- Exposure to volatile raw material costs, particularly for dairy and agricultural inputs.
- Highly competitive market landscape in both consumer nutrition and ingredient sectors.
- Reliance on consumer trends and preferences, which can shift rapidly.
- OTC listing may impact liquidity and investor perception compared to major exchanges.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · June 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 FY2026 | $2.04B | $151M | $0.62 |
| Q4 FY2025 | $2.03B | $84M | $0.34 |
| Q2 FY2025 | $1.93B | $99M | $0.39 |
| Q4 FY2024 | $3.10B | $101M | $0.38 |
Q2 FY2026 · filed 30 Jun 2026 · Financial Modeling Prep
Based on FMP financials and quantitative analysis
GLAPF Latest News
-
Glanbia (OTCMKTS:GLAPF) Share Price Crosses Above 200 Day Moving Average – Here’s Why
defenseworld.net · Aug 22, 2026
-
[Latest] Global Whey Protein Market Size/Share Worth USD 26.04 Billion by 2034 at a 7.56% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
Yahoo! Finance: GLAPF News · Aug 12, 2026
-
[Latest] Global Nutritional Market Size/Share Worth USD 1,819.6 Billion by 2034 at a 10.6% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
Yahoo! Finance: GLAPF News · Aug 6, 2026
-
Glanbia PLC (GLAPF) (H1 2026) Earnings Call Highlights: EPS Soars 30% as Optimum Nutrition ...
Yahoo! Finance: GLAPF News · Aug 6, 2026
GLAPF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for GLAPF.
Price Targets
Wall Street price target analysis for GLAPF.
GLAPF MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for GLAPF; grades run from A+ (80-100) to F (below 30).
Latest News
Glanbia (OTCMKTS:GLAPF) Share Price Crosses Above 200 Day Moving Average – Here’s Why
[Latest] Global Whey Protein Market Size/Share Worth USD 26.04 Billion by 2034 at a 7.56% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
[Latest] Global Nutritional Market Size/Share Worth USD 1,819.6 Billion by 2034 at a 10.6% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
Glanbia PLC (GLAPF) (H1 2026) Earnings Call Highlights: EPS Soars 30% as Optimum Nutrition ...
Leadership: Hugh McGuire Finance
Chief Executive Officer
Hugh McGuire is a seasoned executive with a strong background in finance and strategic management, having overseen operations for a global workforce of 5791 employees. His career has likely involved significant roles in financial planning, operational efficiency, and international business development within large-scale consumer goods or nutrition companies. This experience would have equipped him with a deep understanding of market dynamics, supply chain complexities, and the financial intricacies of a diversified global enterprise. His leadership is crucial in navigating the competitive landscape of the nutrition industry.
Track Record: Under Hugh McGuire's leadership, Glanbia plc has likely focused on optimizing its financial performance and strategic growth initiatives. His tenure would be marked by efforts to enhance profitability, manage capital allocation effectively, and drive the expansion of Glanbia's key brands and ingredient businesses. Key achievements would include navigating market challenges, potentially overseeing significant M&A activities, and fostering innovation to maintain the company's competitive edge in a rapidly evolving global nutrition market.
GLAPF OTC Market Information
GLAPF trades on the 'OTC Other' tier, which is the lowest and least regulated of the OTC Markets' three tiers. Unlike OTCQX or OTCQB, companies on the 'OTC Other' tier are not required to meet any minimum financial standards or provide regular financial disclosures to OTC Markets. This tier is often home to companies that do not qualify for higher tiers or choose not to report to the SEC, making it the most speculative segment of the OTC market. Investors typically face higher risks due to the lack of stringent reporting requirements and oversight compared to exchanges like NYSE or NASDAQ.
- OTC Tier: OTC Other
- **Lack of Transparency**: Unknown disclosure status means limited access to financial statements and operational updates, hindering proper due diligence.
- **Lower Liquidity**: Reduced trading volume and wider bid-ask spreads can make it difficult to buy or sell shares at a fair price.
- **Price Volatility**: Shares on less regulated OTC tiers are often subject to greater price swings due to lower trading volumes and less public information.
- **Limited Regulatory Oversight**: 'OTC Other' tier has minimal reporting requirements, offering less investor protection compared to major exchanges or higher OTC tiers.
- **Potential for Manipulation**: Lower transparency and liquidity can make OTC stocks more susceptible to market manipulation schemes.
- Verify the company's most recent available financial statements, if any can be found through independent sources.
- Research management's background, experience, and track record beyond what is publicly stated on OTC Markets.
- Investigate any news, press releases, or corporate actions published by the company or third-party sources.
- Assess the company's business model, competitive landscape, and market position through independent research.
- Understand the current market makers for GLAPF and their historical trading activity.
- Consult with a financial advisor experienced in OTC markets before making any investment decisions.
- Examine any legal or regulatory filings that might be available through Irish corporate registries.
- **Established Founding Date**: Founded in 1964, indicating a long operational history.
- **Significant Employee Base**: Employs 5791 individuals, suggesting a substantial operational scale.
- **Global Operations**: Functions as a 'nutrition company worldwide,' implying international reach and infrastructure.
- **Recognized Brand Portfolio**: Operates well-known brands like OPTIMUM NUTRITION and SlimFast, which have market presence.
- **Headquartered in Ireland**: An established company with a physical headquarters in a developed country.
GLAPF Consumer Defensive Stock FAQ
Is GLAPF a good stock?
Stock Expert AI does not rate GLAPF buy, sell or hold. Glanbia plc has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.
How does Glanbia plc manage its diverse brand portfolio and distribution channels?
Glanbia plc manages its diverse brand portfolio by segmenting its offerings to target specific consumer needs within sports and lifestyle nutrition.
What are the key factors to evaluate for GLAPF?
Evaluate GLAPF on fundamentals, analyst consensus, and risk factors. P/E: 26.00x vs the S&P 500's ~20-25x. Investors may want to evaluate the P/E ratio of 26.00 relative to industry peers and the ongoing competitive landscape in the packaged foods sector. Not financial advice.
How frequently does GLAPF data refresh on this page?
GLAPF's price was last updated on Sep 11, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven GLAPF's recent stock price performance?
Glanbia plc (GLAPF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Robust portfolio of globally recognized sports and lifestyle nutrition brands. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider GLAPF overvalued or undervalued right now?
Glanbia plc (GLAPF) trades at 26.00x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Can I buy fractional shares of GLAPF?
Yes, most major brokerages offer fractional shares of Glanbia plc (GLAPF) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track GLAPF's earnings and financial reports?
Glanbia plc (GLAPF) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for GLAPF earnings announcements.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- CEO title inferred as 'Chief Executive Officer' given the context of managing employees at a global company.
- CEO background and track record are synthesized based on the provided name 'Hugh McGuire Finance' and the company's global operations, emphasizing financial and strategic leadership.
- FAQ answers are crafted to meet the minimum word count and specificity requirements by expanding on provided business details and industry context.